Cargando…
Pulmonary function abnormality in patients recovered from Covid 19 pneumonia, in a tertiary care hospital in India
BACKGROUND: One of the most dreaded complications of COVID pneumonia is post-COVID residual lung fibrosis and lung function impairment. OBJECTIVES: To find out the extent and type of pulmonary function abnormality using spirometry, diffusion capacity, and 6-minute walk test and to co-relate with the...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298824/ https://www.ncbi.nlm.nih.gov/pubmed/37148023 http://dx.doi.org/10.4103/lungindia.lungindia_15_23 |
Sumario: | BACKGROUND: One of the most dreaded complications of COVID pneumonia is post-COVID residual lung fibrosis and lung function impairment. OBJECTIVES: To find out the extent and type of pulmonary function abnormality using spirometry, diffusion capacity, and 6-minute walk test and to co-relate with the clinical severity at the time of infection, in patients who have recovered from COVID19 pneumonia, in a tertiary care hospital in India. MATERIALS AND METHODS: This is a prospective, cross-sectional study with a total 100 patients. Patients who have recovered from COVID pneumonia after one month of onset of symptoms and before 3 months who come for follow-up and have respiratory complaints undergo pulmonary function test will be recruited in the study. RESULTS: In our study, the most common lung function abnormality detected was restrictive pattern in 55% of the patients (N = 55) followed by mixed pattern in 9% of patients (N = 9), obstructive in 5% of patients (N = 5), and normal in 31% of patients (N = 31). In our study, total lung capacity was reduced in 62% of the patients and normal in 38% of the patients and diffusion capacity of lung was reduced in 52% of the patients recovered from 52% of the individuals. Also, a 6-minute walk test was reduced in 15% of the patients and normal in 85% of the patients. CONCLUSION: Pulmonary function test can serve as an important tool in both diagnosis and follow-up of post-COVID lung fibrosis and pulmonary sequalae. |
---|